Dolipol
Brand names,
Dolipol
Analogs
Dolipol
Brand Names Mixture
Dolipol
Chemical_Formula
C12H18N2O3S
Dolipol
RX_link
No information avaliable
Dolipol
fda sheet
Dolipol
msds (material safety sheet)
Dolipol
Synthesis Reference
No information avaliable
Dolipol
Molecular Weight
270.349 g/mol
Dolipol
Melting Point
128.5 oC
Dolipol
H2O Solubility
109 mg/L
Dolipol
State
Solid
Dolipol
LogP
2.765
Dolipol
Dosage Forms
Tablet (250 and 500 mg)
Dolipol
Indication
Used as an oral hypoglycemic agent in non-insulin-dependent (type 2) Diabetes Miletus with adult onset.
Dolipol
Pharmacology
Tolbutamide, a second-generation sulfonylurea antidiabetic agent, is used with diet to lower blood glucose levels in patients with diabetes mellitus type II. Tolbutamide is twice as potent as the related second-generation agent glipizide. Tolbutamide lowers blood sugar by stimulating the pancreas to secrete insulin and helping the body use insulin efficiently. The pancreas must be able to produce insulin for this drug to work.
Dolipol
Absorption
Well absorbed. Absorption is unaltered if taken with food but is increased with high pH.
Dolipol
side effects and Toxicity
Oral, mouse: LD50 = 2600 mg/kg
Dolipol
Patient Information
Treatment with tolbutamide may increase the risk of death from cardiovascular disease compared to treatment of diabetes with diet alone or diet plus insulin. Discuss with your doctor the risks and benefits of treatment with tolbutamide. Know the signs and symptoms of low blood sugar (hypoglycemia), which include headache, drowsiness, weakness, dizziness, fast heartbeat, sweating, tremor, and nausea. Carry a piece of hard candy or glucose tablets with you to treat episodes of low blood sugar. Follow your diet, medication, and exercise routines closely. Changing any of them can affect blood sugar levels. Do not change your dose of tolbutamide without first talking to your doctor. Avoid alcohol. It lowers blood sugar and may interfere with your diabetes treatment.
Dolipol
Organisms Affected
Humans and other mammals